- Home
- FOFO vs INCR Comparison
FOFO vs INCR Comparison
Compare FOFO & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOFO | INCR |
|---|---|---|
| Founded | 2017 | 1994 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.2M | 79.3M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | FOFO | INCR |
|---|---|---|
| Price | $5.74 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 64.6K | ★ 168.2K |
| Earning Date | 03-13-2026 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | $3,117,608.00 | ★ $72,158,312.00 |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | $15.35 | ★ N/A |
| Revenue Growth | ★ 1597.65 | N/A |
| 52 Week Low | $4.53 | $0.68 |
| 52 Week High | $68.00 | $1.78 |
Technical Indicators
Market Signals| Indicator | FOFO | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 35.46 |
| Support Level | $5.56 | $0.90 |
| Resistance Level | $6.14 | $0.97 |
| Average True Range (ATR) | 0.50 | 0.04 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 16.82 | 34.60 |
Price Performance
Historical ComparisonAbout FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.